Navigation Links
PCI Appoints John Davis, PE, to Board

Raleigh, NC (PRWEB) March 14, 2013

PCI, a leading provider of calibration and maintenance services to the Life Sciences industry is pleased to announce the recent appointment of John Davis, PE, to the PCI Board. Mr. Davis has been a leader in the biotech and pharmaceutical industries for 30 years. He has proven his skills as a leader at various pharmaceutical companies and equally demonstrated his ability to lead as an entrepreneur.

PCI is experiencing exciting growth, with new locations and an increasing client list. The Board plays an integral part, ensuring the PCI success philosophy will positively impact new and existing clients. “PCI is thrilled to have John join our Board. John brings a unique perspective with his consulting company experience and his experience in senior management with large pharmaceutical and biotech operating companies,” said Andy Ferrell, PCI CEO.

Mr. Davis was the founder and president of Serentec, Inc., an international pharmaceutical services firm that was subsequently acquired by Lloyd’s Register in 2002. Currently Associate Director, IT at Biogen Idec, Mr. Davis’ career included leadership and technical roles with Eisai, Glaxo Wellcome, Burroughs-Wellcome, Fluor Daniel and Pitman Moore. He has been involved in IT, process automation, systems design, implementation and validation in the biotech and pharmaceutical industries since 1982.

Earning his B.S. degree in Chemistry from Indiana State University, Mr. Davis is a registered professional engineer and received his MBA from UNC’s Kenan-Flagler School of Business. “I am excited to join the PCI Board. It will be a rewarding experience to be part of such a successful and driven company,” said Mr. Davis.

To see more on the PCI Board Members, visit

About PCI:
PCI was founded in 1996 with a vision of becoming the best consulting and technical services firm in the life sciences industry. The company’s core expertise is calibration and maintenance compliance for FDA-regulated manufacturing facilities and laboratories. PCI’s mission is to provide personalized customer service, exceptional and quality documentation to their customers while always preserving the integrity and ingenuity of performance. The company places high value on honesty, integrity, pride, self-esteem and teamwork. PCI take these values and mission as their primary focus in creating the ultimate result for clients: total compliance in the product quality life cycle.

PCI offers a comprehensive selection of quality services that include Calibration & Maintenance Consulting, Process & Analytical Equipment Calibrations, and ISO 17025 accredited Metrology Laboratory. The company’s six regional offices are located in Boston, Gaithersburg, Indianapolis, Raleigh, San Francisco and Seattle.

To learn more about PCI and its services, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. California Healthcare Institute Appoints Vice President-State Government Affairs
2. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
3. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
4. Creabilis Appoints Catherine Moukheibir to its Board of Directors
5. Verenium Appoints Holger Liepmann To Its Board Of Directors
6. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
7. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
8. Avantium Appoints Jonathan Wolfson to its Supervisory Board
9. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
10. PCI Appoints Jose Solorio-Ruiz, MBA, Manager of West Coast Operations
11. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Post Your Comments:
(Date:11/24/2015)... 24, 2015  Twist Bioscience, a company focused ... Ph.D., Twist Bioscience chief executive officer, will present ... December 1, 2015 at 3:10 p.m. Eastern Time at The ... --> --> ... Bioscience is on Twitter. Sign up to follow ...
(Date:11/24/2015)... , Nov. 24, 2015 Capricor Therapeutics, ... focused on the discovery, development and commercialization of first-in-class ... Chief Executive Officer, is scheduled to present at the ... at 10:50 a.m. EST, at The Lotte New York ... . . --> ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... ... 23, 2015 , ... Noblis, Inc., a leading provider of science, technology, and ... Geospatial Intelligence Agency (NGA), has joined the Noblis NSP team as President of the ... intelligence community and the private sector,” said L. Roger Mason, Jr., Ph.D. , ...
Breaking Biology Technology:
(Date:11/18/2015)... -- As new scientific discoveries deepen our understanding of how ... face challenges in better using that knowledge to guide ... more children continue to survive pediatric cancer, that counseling ... John M. Maris, M.D ., a pediatric ... . --> John M. Maris, M.D ...
(Date:11/17/2015)... Calif. , Nov. 17, 2015  Vigilant Solutions ... has joined its Board of Directors. ... Board after recently retiring from the partnership at TPG ... 107 companies with over $140 Billion in revenue.  He ... improvement across all the TPG companies, from 1997 to ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
Breaking Biology News(10 mins):